These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 37326289)

  • 1. Production of a promising modular proteinaceous self-assembled delivery system for vaccination.
    Pan C; Ye J; Zhang S; Li X; Shi Y; Guo Y; Wang K; Sun P; Wu J; Wang H; Zhu L
    Nanoscale; 2023 Jun; 15(25):10794-10807. PubMed ID: 37326289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biosynthesis of Self-Assembled Proteinaceous Nanoparticles for Vaccination.
    Pan C; Wu J; Qing S; Zhang X; Zhang L; Yue H; Zeng M; Wang B; Yuan Z; Qiu Y; Ye H; Wang D; Liu X; Sun P; Liu B; Feng E; Gao X; Zhu L; Wei W; Ma G; Wang H
    Adv Mater; 2020 Oct; 32(42):e2002940. PubMed ID: 32881121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of Orthogonal Modular Proteinaceous Nanovaccine Delivery Vectors Based on mSA-Biotin Binding.
    Shi Y; Pan C; Wang K; Liu Y; Sun Y; Guo Y; Sun P; Wu J; Lu Y; Zhu L; Wang H
    Nanomaterials (Basel); 2022 Feb; 12(5):. PubMed ID: 35269221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-Assembled Proteinaceous Nanoparticles for Co-Delivery of Antigens and Cytosine Phosphoguanine (CpG) Adjuvants: Implications for Nanovaccines.
    Li X; Pan C; Li C; Wang K; Ye J; Sun P; Guo Y; Wu J; Wang H; Zhu L
    ACS Appl Nano Mater; 2023 May; 6(9):7637-7648. PubMed ID: 37207131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new polysaccharide platform constructs self-adjuvant nanovaccines to enhance immune responses.
    Chen S; Yang L; Ou X; Li JY; Zi CT; Wang H; Hu JM; Liu Y
    J Nanobiotechnology; 2022 Jul; 20(1):320. PubMed ID: 35836236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.
    Garrett ME; Galloway JG; Wolf C; Logue JK; Franko N; Chu HY; Matsen FA; Overbaugh JM
    Elife; 2022 Jan; 11():. PubMed ID: 35072628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous capsid-forming protein ARC for self-assembling nanoparticle vaccines.
    Li Y; Zhao X; Tang J; Yi M; Zai X; Zhang J; Cheng G; Yang Y; Xu J
    J Nanobiotechnology; 2024 Aug; 22(1):513. PubMed ID: 39192264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peritoneal Administration of a Subunit Vaccine Encapsulated in a Nanodelivery System Not Only Augments Systemic Responses against SARS-CoV-2 but Also Stimulates Responses in the Respiratory Tract.
    Jearanaiwitayakul T; Apichirapokey S; Chawengkirttikul R; Limthongkul J; Seesen M; Jakaew P; Trisiriwanich S; Sapsutthipas S; Sunintaboon P; Ubol S
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 spike produced in insect cells elicits high neutralization titres in non-human primates.
    Li T; Zheng Q; Yu H; Wu D; Xue W; Xiong H; Huang X; Nie M; Yue M; Rong R; Zhang S; Zhang Y; Wu Y; Wang S; Zha Z; Chen T; Deng T; Wang Y; Zhang T; Chen Y; Yuan Q; Zhao Q; Zhang J; Gu Y; Li S; Xia N
    Emerg Microbes Infect; 2020 Dec; 9(1):2076-2090. PubMed ID: 32897177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigen epitope-TLR7/8a conjugate as self-assembled carrier-free nanovaccine for personalized immunotherapy.
    Song H; Su Q; Shi W; Huang P; Zhang C; Zhang C; Liu Q; Wang W
    Acta Biomater; 2022 Mar; 141():398-407. PubMed ID: 35007785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization with synthetic SARS-CoV-2 S glycoprotein virus-like particles protects macaques from infection.
    Sulbaran G; Maisonnasse P; Amen A; Effantin G; Guilligay D; Dereuddre-Bosquet N; Burger JA; Poniman M; Grobben M; Buisson M; Dergan Dylon S; Naninck T; Lemaître J; Gros W; Gallouët AS; Marlin R; Bouillier C; Contreras V; Relouzat F; Fenel D; Thepaut M; Bally I; Thielens N; Fieschi F; Schoehn G; van der Werf S; van Gils MJ; Sanders RW; Poignard P; Le Grand R; Weissenhorn W
    Cell Rep Med; 2022 Feb; 3(2):100528. PubMed ID: 35233549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An efficient approach for SARS-CoV-2 monoclonal antibody production via modified mRNA-LNP immunization.
    Hsu FF; Liang KH; Kumari M; Chen WY; Lin HT; Cheng CM; Tao MH; Wu HC
    Int J Pharm; 2022 Nov; 627():122256. PubMed ID: 36198358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carrier-free subunit nanovaccine amplifies immune responses against tumors and viral infections.
    Chen H; Li Y; Li L; Yang Z; Wen Z; Liu L; Liu H; Chen Y
    Acta Biomater; 2023 Mar; 158():525-534. PubMed ID: 36572250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA vaccination induced protective immunity against SARS CoV-2 infection in hamsterss.
    Chai KM; Tzeng TT; Shen KY; Liao HC; Lin JJ; Chen MY; Yu GY; Dou HY; Liao CL; Chen HW; Liu SJ
    PLoS Negl Trop Dis; 2021 May; 15(5):e0009374. PubMed ID: 34043618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Integrated Platform for Serological Detection and Vaccination of COVID-19.
    Wei SC; Hsu WT; Chiu CH; Chang FY; Lo HR; Liao CY; Yang HI; Chou YC; Tsai CH; Chao YC
    Front Immunol; 2021; 12():771011. PubMed ID: 35003088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A self-amplifying mRNA SARS-CoV-2 vaccine candidate induces safe and robust protective immunity in preclinical models.
    Maruggi G; Mallett CP; Westerbeck JW; Chen T; Lofano G; Friedrich K; Qu L; Sun JT; McAuliffe J; Kanitkar A; Arrildt KT; Wang KF; McBee I; McCoy D; Terry R; Rowles A; Abrahim MA; Ringenberg MA; Gains MJ; Spickler C; Xie X; Zou J; Shi PY; Dutt T; Henao-Tamayo M; Ragan I; Bowen RA; Johnson R; Nuti S; Luisi K; Ulmer JB; Steff AM; Jalah R; Bertholet S; Stokes AH; Yu D
    Mol Ther; 2022 May; 30(5):1897-1912. PubMed ID: 34990810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A nanotechnological approach in the current therapy of COVID-19: model drug oseltamivir-phosphate loaded PLGA nanoparticles targeted with spike protein binder peptide of SARS-CoV-2.
    Ucar B; Acar T; Arayici PP; Derman S
    Nanotechnology; 2021 Sep; 32(48):. PubMed ID: 34375967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting SARS-CoV-2 receptor-binding domain to cells expressing CD40 improves protection to infection in convalescent macaques.
    Marlin R; Godot V; Cardinaud S; Galhaut M; Coleon S; Zurawski S; Dereuddre-Bosquet N; Cavarelli M; Gallouët AS; Maisonnasse P; Dupaty L; Fenwick C; Naninck T; Lemaitre J; Gomez-Pacheco M; Kahlaoui N; Contreras V; Relouzat F; Fang RHT; Wang Z; Ellis J; Chapon C; Centlivre M; Wiedemann A; Lacabaratz C; Surenaud M; Szurgot I; Liljeström P; Planas D; Bruel T; Schwartz O; Werf SV; Pantaleo G; Prague M; Thiébaut R; Zurawski G; Lévy Y; Grand RL
    Nat Commun; 2021 Sep; 12(1):5215. PubMed ID: 34471122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamics of SARS-CoV-2 Spike Proteins in Cell Entry: Control Elements in the Amino-Terminal Domains.
    Qing E; Kicmal T; Kumar B; Hawkins GM; Timm E; Perlman S; Gallagher T
    mBio; 2021 Aug; 12(4):e0159021. PubMed ID: 34340537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A vesicular stomatitis virus-based prime-boost vaccination strategy induces potent and protective neutralizing antibodies against SARS-CoV-2.
    Kim GN; Choi JA; Wu K; Saeedian N; Yang E; Park H; Woo SJ; Lim G; Kim SG; Eo SK; Jeong HW; Kim T; Chang JH; Seo SH; Kim NH; Choi E; Choo S; Lee S; Winterborn A; Li Y; Parham K; Donovan JM; Fenton B; Dikeakos JD; Dekaban GA; Haeryfar SMM; Troyer RM; Arts EJ; Barr SD; Song M; Kang CY
    PLoS Pathog; 2021 Dec; 17(12):e1010092. PubMed ID: 34914812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.